Skip to content

Wojciech Jurczak

  • MD, PHD, Professor
  • The Head of Lymphoma Team
  • Jagiellonian University Medical College
  • 19h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 2123CitationsNumber of citations received by Wojciech's publications. Updated daily.

Other IDs

Research interests

anti-PD1MoAbIP3 inhibitorsBTK inhibitorslymphoma

Co-authors (500)

Publications (5)

  • Brentuximab vedotin with chemotherapy for stage III or IV Hodgkin's lymphoma

    • Connors J
    • Jurczak W
    • Straus D
    • et al.
    N/AReaders
    22Citations
    Get full text
  • Ibrutinib versus temsirolimus: 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY study

    • Rule S
    • Jurczak W
    • Jerkeman M
    • et al.
    N/AReaders
    1Citations
    Get full text
  • Phase IIa study of the CD19 antibody MOR208 in patients with relapsed or refractory B-cell non- Hodgkin's lymphoma

    • Jurczak W
    • Zinzani P
    • Gaidano G
    • et al.
    N/AReaders
    2Citations
    Get full text
  • Venetoclax for patients with chronic lymphocytic leukemia with 17p deletion: Results from the full population of a phase ii pivotal trial

    • Stilgenbauer S
    • Eichhorst B
    • Schetelig J
    • et al.
    N/AReaders
    3Citations
    Get full text
  • Rituximab – the first biosimilar monoclonal antibodies in hematooncology

    • Giannopoulos K
    • Wróbel T
    • Jurczak W
    • et al.
    N/AReaders
    0Citations
    Get full text

Professional experience

The Head of Lymphoma Team

Uniwersytet Jagielloński - Collegium Medicum

January 2002 - Present